{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:36:53Z","timestamp":1771943813246,"version":"3.50.1"},"publisher-location":"Cham","reference-count":95,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319442501","type":"print"},{"value":"9783319442518","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/5584_2016_26","type":"book-chapter","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T03:56:47Z","timestamp":1479441407000},"page":"215-237","source":"Crossref","is-referenced-by-count":25,"title":["Endocrine Hypertension: A Practical Approach"],"prefix":"10.1007","author":[{"given":"Joseph M.","family":"Pappachan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harit N.","family":"Buch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"26_CR1","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.surg.2013.06.047","volume":"154","author":"G Agarwal","year":"2013","unstructured":"Agarwal G, Nanda G, Kapoor A, Singh KR, Chand G, Mishra A et al (2013) Cardiovascular dysfunction in symptomatic primary hyperparathyroidism and its reversal after curative parathyroidectomy: results of a prospective case control study. Surgery 154:1394\u20131403","journal-title":"Surgery"},{"key":"26_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0029-7844(97)84258-5","volume":"89","author":"AA Akkad","year":"1997","unstructured":"Akkad AA, Halligan AW, Abrams K, al-Azzawi F (1997) Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 89:97\u2013103","journal-title":"Obstet Gynecol"},{"key":"26_CR3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1530\/EJE-09-0046","volume":"160","author":"KI Alexandraki","year":"2009","unstructured":"Alexandraki KI, Kaltsas GA, Isidori AM, Akker SA, Drake WM, Chew SL et al (2009) The prevalence and characteristic features of cyclicity and variability in Cushing\u2019s disease. Eur J Endocrinol 160:1011\u20131018","journal-title":"Eur J Endocrinol"},{"key":"26_CR4","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1210\/jc.2009-0370","volume":"94","author":"P Anagnostis","year":"2009","unstructured":"Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP (2009) The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 94:2692\u20132701","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1210\/jc.2013-2117","volume":"99","author":"X Bertagna","year":"2014","unstructured":"Bertagna X, Pivonello R, Fleseriu M, Zhang Y, Robinson P, Taylor A et al (2014) LCI699, a potent 11\u03b2-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing\u2019s disease: results from a ulticentre, proof-of-concept study. J Clin Endocrinol Metab 99:1375\u20131383","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fendo.2015.00095","volume":"6","author":"S Boulkroun","year":"2015","unstructured":"Boulkroun S, Fernandes-Rosa FL, Zennaro MC (2015) Molecular and cellular mechanisms of aldosterone producing adenoma development. Front Endocrinol (Lausanne) 6:95","journal-title":"Front Endocrinol (Lausanne)"},{"key":"26_CR7","doi-asserted-by":"publisher","first-page":"309068","DOI":"10.1155\/2011\/309068","volume":"2011","author":"PD Broulik","year":"2011","unstructured":"Broulik PD, Broulikov\u00e1 A, Ad\u00e1mek S, Libansk\u00fd P, Tvrdo\u0148 J, Broulikova K et al (2011) Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism. Int J Endocrinol 2011:309068","journal-title":"Int J Endocrinol"},{"key":"26_CR8","doi-asserted-by":"publisher","first-page":"T141","DOI":"10.1530\/JOE-15-0109","volume":"226","author":"C Capatina","year":"2015","unstructured":"Capatina C, Wass JA (2015) 60 years of neuroendocrinology: acromegaly. J Endocrinol 226:T141\u2013T160","journal-title":"J Endocrinol"},{"key":"26_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12020-011-9517-7","volume":"41","author":"H Chen","year":"2012","unstructured":"Chen H, Xi Q, Zhang H, Song B, Liu X, Mao X et al (2012) Investigation of thyroid function and blood pressure in school-aged subjects without overt thyroid disease. Endocrine 41:122\u2013129","journal-title":"Endocrine"},{"key":"26_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1210\/jc.2010-1942","volume":"96","author":"RN Clayton","year":"2011","unstructured":"Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing\u2019s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96:632\u2013642","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR11","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1105743","volume":"366","author":"A Colao","year":"2012","unstructured":"Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M et al (2012) A 12-month phase 3 study of pasireotide in Cushing\u2019s disease. New Engl J Med 366:914\u2013924","journal-title":"New Engl J Med"},{"key":"26_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1210\/jc.2013-2480","volume":"99","author":"A Colao","year":"2014","unstructured":"Colao A, Bronstein MD, Freda P et al (2014) Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab 99:791\u2013799","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR13","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1530\/EJE-15-0209","volume":"173","author":"R Correa","year":"2015","unstructured":"Correa R, Salpea P, Stratakis C (2015) Carney complex: an update. Eur J Endocrinol 173:M85\u2013M97","journal-title":"Eur J Endocrinol"},{"key":"26_CR14","doi-asserted-by":"publisher","first-page":"R263","DOI":"10.1530\/EJE-14-1014","volume":"172","author":"E Daniel","year":"2015","unstructured":"Daniel E, Newell-Price JD (2015) Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing\u2019s syndrome. Eur J Endocrinol 172:R263\u2013R280","journal-title":"Eur J Endocrinol"},{"key":"26_CR15","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/jc.2015-2616","volume":"100","author":"E Daniel","year":"2015","unstructured":"Daniel E, Aylwin S, Mustafa O, Ball S, Munir A, Boelaert K et al (2015) Effectiveness of metyrapone in treating Cushing\u2019s Syndrome: a retrospective multicenter study in 195 patients. J Clin Endocrinol Metab 100:4146\u20134154","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000318566","volume":"92","author":"M Leo De","year":"2010","unstructured":"De Leo M, Pivonello R, Auriemma RS, Cozzolino A, Vitale P, Simeoli C et al (2010) Cardiovascular disease in Cushing\u2019s syndrome: heart versus vasculature. Neuroendocrinology 92:50\u201354","journal-title":"Neuroendocrinology"},{"key":"26_CR17","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMcps0708258","volume":"361","author":"AS Desai","year":"2009","unstructured":"Desai AS, Chutkow WA, Edelman E, Economy KE, Dec GW Jr (2009) Clinical problem-solving. A crisis in late pregnancy. N Engl J Med 361:2271\u20132277","journal-title":"N Engl J Med"},{"key":"26_CR18","doi-asserted-by":"publisher","first-page":"M61","DOI":"10.1530\/EJE-15-0272","volume":"173","author":"G Dalmazi Di","year":"2015","unstructured":"Di Dalmazi G, Pasquali R, Beuschlein F, Reincke M (2015) Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur J Endocrinol 173:M61\u2013M71","journal-title":"Eur J Endocrinol"},{"key":"26_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/jc.2009-1317","volume":"95","author":"B Donadille","year":"2010","unstructured":"Donadille B, Groussin L, Waintrop C, Abbas H, Tenenbaum F, Dugue MA (2010) Management of Cushing\u2019s syndrome due to ectopic adrenocorticotropin secretion with 1, ortho-1, para\u2019-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single center. J Clin Endocrinol Metab 95:537\u2013544","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR20","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1210\/jc.2002-030005","volume":"88","author":"G Eisenhofer","year":"2003","unstructured":"Eisenhofer G, Goldstein DS, Walther MM et al (2003) Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 88:2656\u20132666","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR21","unstructured":"European Medicines Agency (2016) Ketoconazole HRA recommended for approval in Cushing\u2019s syndrome. Available from URL: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl \u2009=\u2009pages\/news_and_events\/news\/2014\/09\/news_detail_002174.jsp&mid\u2009=\u2009WC0b01ac058004d5c1. Assessed 02 Feb 2016"},{"key":"26_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4065\/84.1.65","volume":"84","author":"V Fatourechi","year":"2009","unstructured":"Fatourechi V (2009) Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc 84:65\u201371","journal-title":"Mayo Clin Proc"},{"key":"26_CR23","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJMc1000094","volume":"362","author":"RA Feelders","year":"2010","unstructured":"Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR et al (2010) Pasireotide alone or with cabergoline and ketoconazole in Cushing\u2019s disease. New Engl J Med 362:1846\u20131848","journal-title":"New Engl J Med"},{"key":"26_CR24","doi-asserted-by":"publisher","first-page":"M133","DOI":"10.1530\/EJE-15-0354","volume":"173","author":"F Ferra\u00f9","year":"2015","unstructured":"Ferra\u00f9 F, Korbonits M (2015) Metabolic comorbidities in Cushing\u2019s syndrome. Eur J Endocrinol 173:M133\u2013M157","journal-title":"Eur J Endocrinol"},{"key":"26_CR25","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1210\/jc.2011-3350","volume":"97","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C et al (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97:2039\u20132049","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR26","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMcpc1215971","volume":"368","author":"JC Florez","year":"2013","unstructured":"Florez JC, Shepard JA, Kradin RL (2013) Case records of the Massachusetts General Hospital. Case 17\u20132013. A 56-year-old woman with poorly controlled diabetes mellitus and fatigue. N Engl J Med 368:2126\u20132136","journal-title":"N Engl J Med"},{"key":"26_CR27","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M et al (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266\u20133281","journal-title":"J Clin Endocrinol Metab"},{"issue":"5476","key":"26_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1126\/science.289.5476.119","volume":"289","author":"DS Geller","year":"2000","unstructured":"Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A et al (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289(5476):119\u2013123","journal-title":"Science"},{"key":"26_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","volume":"23","author":"D Graversen","year":"2012","unstructured":"Graversen D, Vestergaard P, Stochholm K, Gravholt CH, J\u00f8rgensen JO (2012) Mortality in Cushing\u2019s syndrome: a systematic review and meta-analysis. Eur J Intern Med 23:278\u2013282","journal-title":"Eur J Intern Med"},{"key":"26_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.atherosclerosis.2014.12.027","volume":"238","author":"E Hagstr\u00f6m","year":"2015","unstructured":"Hagstr\u00f6m E, Ahlstr\u00f6m T, \u00c4rnl\u00f6v J, Larsson A, Melhus H, Hellman P et al (2015) Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort. Atherosclerosis 238:420\u2013426","journal-title":"Atherosclerosis"},{"key":"26_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0031-1295438","volume":"44","author":"A Hannemann","year":"2012","unstructured":"Hannemann A, Wallaschofski H (2012) Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies \u2013 a review of the current literature. Horm Metab Res 44:157\u2013162","journal-title":"Horm Metab Res"},{"key":"26_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7326\/0003-4819-140-2-200401200-00015","volume":"140","author":"M Helfand","year":"2004","unstructured":"Helfand M, U.S. Preventive Services Task Force (2004) Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 140:128\u2013141","journal-title":"Ann Intern Med"},{"key":"26_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489\u2013499","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR34","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1210\/jc.2011-2768","volume":"97","author":"T Ittermann","year":"2012","unstructured":"Ittermann T, Thamm M, Wallaschofski H, Rettig R, V\u00f6lzke H (2012) Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. J Clin Endocrinol Metab 97:828\u2013834","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40001-014-0056-6","volume":"19","author":"S Janjgava","year":"2014","unstructured":"Janjgava S, Zerekidze T, Uchava L, Giorgadze E, Asatiani K (2014) Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency. Eur J Med Res 19:56","journal-title":"Eur J Med Res"},{"key":"26_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1196\/annals.1353.004","volume":"1073","author":"AA Kasperlik-Zaluska","year":"2006","unstructured":"Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J, Otto M, Cichocki A, Cwikla J et al (2006) 1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors. Ann N Y Acad Sci 1073:38\u201346","journal-title":"Ann N Y Acad Sci"},{"key":"26_CR37","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1210\/jc.2010-0670","volume":"95","author":"L Katznelson","year":"2010","unstructured":"Katznelson L (2010) Approach to the patient with persistent acromegaly after pituitary surgery. J Clin Endocrinol Metab 95:4114\u20134123","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR38","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000119417","volume":"31","author":"T Kienitz","year":"2008","unstructured":"Kienitz T, Quinkler M (2008) Testosterone and blood pressure regulation. Kidney Blood Press Res 31:71\u201379","journal-title":"Kidney Blood Press Res"},{"key":"26_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.soc.2015.08.006","volume":"25","author":"CM Kiernan","year":"2016","unstructured":"Kiernan CM, Sol\u00f3rzano CC (2016) Pheochromocytoma and paraganglioma: Diagnosis, genetics, and treatment. Surg Oncol Clin N Am 25:119\u2013138","journal-title":"Surg Oncol Clin N Am"},{"key":"26_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5653\/cerm.2015.42.2.72","volume":"42","author":"SM Kim","year":"2015","unstructured":"Kim SM, Rhee JH (2015) A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med 42:72\u201376","journal-title":"Clin Exp Reprod Med"},{"key":"26_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200105103441901","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344:501\u2013509","journal-title":"N Engl J Med"},{"issue":"13","key":"26_CR43","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1055\/s-0035-1564166","volume":"47","author":"HE Korah","year":"2015","unstructured":"Korah HE, Scholl UI (2015) An update on familial hyperaldosteronism. Horm Metab Res 47(13):941\u2013946. [Epub ahead of print]","journal-title":"Horm Metab Res"},{"key":"26_CR44","doi-asserted-by":"publisher","first-page":"M107","DOI":"10.1530\/EJE-15-0616","volume":"173","author":"O Koulouri","year":"2015","unstructured":"Koulouri O, Steuwe A, Gillett D, Hoole AC, Powlson AS, Donnelly NA et al (2015) A role for 11C-methionine PET imaging in ACTH-dependent Cushing\u2019s syndrome. Eur J Endocrinol 173:M107\u2013M120","journal-title":"Eur J Endocrinol"},{"key":"26_CR45","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915\u20131942","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.jhh.1001907","volume":"19","author":"C Letizia","year":"2005","unstructured":"Letizia C, Ferrari P, Cotesta D, Caliumi C, Cianci R, Cerci S et al (2005) Ambulatory Monitoring of Blood Pressure (AMBP) in patients with primary hyperparathyroidism. J Hum Hypertens 19:901\u2013906","journal-title":"J Hum Hypertens"},{"key":"26_CR47","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1210\/jc.2013-4146","volume":"99","author":"V Lim","year":"2014","unstructured":"Lim V, Guo Q, Grant CS, Thompson GB, Richards ML, Farley DR et al (2014) Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism. J Clin Endocrinol Metab 99:2712\u20132719","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2796.1991.tb00403.x","volume":"230","author":"L Lind","year":"1991","unstructured":"Lind L, Jacobsson S, Palmer M, Lithell H, Wengle B, Ljunghall S (1991) Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases. J Intern Med 230:29\u201335","journal-title":"J Intern Med"},{"key":"26_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","volume":"121","author":"E Lundgren","year":"1997","unstructured":"Lundgren E, Rastad J, Thrufjell E, Akerstrom G, Ljunghall S (1997) Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121:287\u2013294","journal-title":"Surgery"},{"key":"26_CR50","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1097\/HJH.0000000000000727","volume":"33","author":"J Manolopoulou","year":"2015","unstructured":"Manolopoulou J, Fischer E, Dietz A, Diederich S, Holmes D, Junnila R et al (2015) Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J Hypertens 33:2500\u20132511","journal-title":"J Hypertens"},{"key":"26_CR51","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. N Engl J Med 365:2389\u20132397","journal-title":"N Engl J Med"},{"key":"26_CR52","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1055\/s-0032-1321851","volume":"44","author":"E Melcescu","year":"2012","unstructured":"Melcescu E, Phillips J, Moll G, Subauste JS, Koch CA (2012) 11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid excess as a rare cause of endocrine hypertension. Horm Metab Res 44:867\u2013878","journal-title":"Horm Metab Res"},{"key":"26_CR53","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1172\/JCI39375","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119:3189\u20133202","journal-title":"J Clin Invest"},{"key":"26_CR54","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/eje.0.1510439","volume":"151","author":"A Mestron","year":"2004","unstructured":"Mestron A, Webb SM, Astorga R et al (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151:439\u2013446","journal-title":"Eur J Endocrinol"},{"key":"26_CR55","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","volume":"54","author":"AS Mihailidou","year":"2009","unstructured":"Mihailidou AS, Le Loan TY, Mardini M, Funder JW (2009) Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54:1306\u20131312","journal-title":"Hypertension"},{"key":"26_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32:81\u2013151","journal-title":"Endocr Rev"},{"key":"26_CR57","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L et al (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045\u20131050","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1507\/endocrj.EJ11-0406","volume":"59","author":"A Mussa","year":"2012","unstructured":"Mussa A, Camilla R, Monticone S, Porta F, Tessaris D, Verna F et al (2012) Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism. Endocr J 59:497\u2013502","journal-title":"Endocr J"},{"key":"26_CR59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/bjs.9744","volume":"102","author":"A Muth","year":"2015","unstructured":"Muth A, Ragnarsson O, Johannsson G, W\u00e4ngberg B (2015) Systematic review of surgery and outcomes in patients with primary aldosteronism. Br J Surg 102:307\u2013317","journal-title":"Br J Surg"},{"key":"26_CR60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/jcem-55-2-303","volume":"55","author":"JC Nainby-Luxmoore","year":"1982","unstructured":"Nainby-Luxmoore JC, Langford HG, Nelson NC, Watson RL, Barnes TY (1982) A case-comparison study of hypertension and hyperparathyroidism. J Clin Endocrinol Metab 55:303\u2013306","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tem.2005.02.011","volume":"16","author":"MI New","year":"2005","unstructured":"New MI, Geller DS, Fallo F, Wilson RC (2005) Monogenic low renin hypertension. Trends Endocrinol Metab 16:92\u201397","journal-title":"Trends Endocrinol Metab"},{"key":"26_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1022308429992","volume":"5","author":"LK Nieman","year":"2002","unstructured":"Nieman LK (2002) Medical therapy of Cushing\u2019s disease. Pituitary 5:77\u201382","journal-title":"Pituitary"},{"key":"26_CR63","doi-asserted-by":"publisher","first-page":"M33","DOI":"10.1530\/EJE-15-0464","volume":"173","author":"LK Nieman","year":"2015","unstructured":"Nieman LK (2015) Cushing\u2019s syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol 173:M33\u2013M38","journal-title":"Eur J Endocrinol"},{"key":"26_CR64","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM et al (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93:1526\u20131540","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR65","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO et al (2015) Treatment of Cushing\u2019s syndrome: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100:2807\u20132831","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR66","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11906-014-0442-z","volume":"16","author":"JM Pappachan","year":"2014","unstructured":"Pappachan JM, Raskauskiene D, Sriraman R, Edavalath M, Hanna FW (2014) Diagnosis and management of pheochromocytoma: a practical guide to clinicians. Curr Hypertens Rep 16:442","journal-title":"Curr Hypertens Rep"},{"key":"26_CR67","doi-asserted-by":"publisher","first-page":"872713","DOI":"10.1155\/2012\/872713","volume":"2012","author":"G Parenti","year":"2012","unstructured":"Parenti G, Zampetti B, Rapizzi E et al (2012) Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma\/paraganglioma. J Oncol 2012:872713","journal-title":"J Oncol"},{"key":"26_CR68","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1210\/jc.2012-2328","volume":"97","author":"F Pecori Giraldi","year":"2012","unstructured":"Pecori Giraldi F, Ambrogio AG, Andrioli M, Sanguin F, Karamouzis I, Corsello SM et al (2012) Potential role for retinoic acid in patients with Cushing\u2019s disease. J Clin Endocrinol Metab 97:3577\u20133583","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR69","doi-asserted-by":"publisher","first-page":"R191","DOI":"10.1530\/EJE-14-0537","volume":"172","author":"G Piaditis","year":"2015","unstructured":"Piaditis G, Markou A, Papanastasiou L, Androulakis II, Kaltsas G (2015) Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension. Eur J Endocrinol 172:R191\u2013R203","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"26_CR70","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/13697130902775788","volume":"12","author":"RA Preston","year":"2009","unstructured":"Preston RA (2009) Comparative effects of conventional vs. novel hormone replacement therapy on blood pressure in postmenopausal women. Climacteric 12(Suppl 1):66\u201370","journal-title":"Climacteric"},{"key":"26_CR71","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.11388","volume":"49","author":"A Proven","year":"2003","unstructured":"Proven A, Gabriel SE, Orces C, O\u2019Fallon WM, Hunder GG (2003) Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 49:703\u2013708","journal-title":"Arthritis Rheum"},{"key":"26_CR72","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1210\/jc.2010-0573","volume":"95","author":"M Puig-Domingo","year":"2010","unstructured":"Puig-Domingo M, Resmini E, Gomez-Anson B et al (2010) Magnetic resonance imaging as a predictor of response to somatostatin analogues in acromegaly after surgical failure. J Clin Endocrinol Metab 95:4973\u20134978","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"26_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000167216","volume":"6","author":"A Rapado","year":"1986","unstructured":"Rapado A (1986) Arterial hypertension and primary hyperparathyroidism. Incidence and follow-up after parathyroidectomy. Am J Nephrol 6(Suppl 1):49\u201350","journal-title":"Am J Nephrol"},{"key":"26_CR74","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1530\/EJE-15-0690","volume":"173","author":"M Reincke","year":"2015","unstructured":"Reincke M (2015) Improving outcome in Cushing\u2019s syndrome. Eur J Endocrinol 173:E3\u2013E5","journal-title":"Eur J Endocrinol"},{"key":"26_CR75","doi-asserted-by":"publisher","first-page":"M23","DOI":"10.1530\/EJE-15-0265","volume":"173","author":"M Reincke","year":"2015","unstructured":"Reincke M, Ritzel K, O\u00dfwald A, Berr C, Stalla G, Hallfeldt K, Reisch N et al (2015) A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing\u2019s syndrome. Eur J Endocrinol 173:M23\u2013M32","journal-title":"Eur J Endocrinol"},{"key":"26_CR76","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","volume":"35","author":"SF Rimoldi","year":"2014","unstructured":"Rimoldi SF, Scherrer U, Messerli FH (2014) Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 35:1245\u20131254","journal-title":"Eur Heart J"},{"key":"26_CR77","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/BF01726908","volume":"62","author":"JD Ringe","year":"1984","unstructured":"Ringe JD (1984) Reversible hypertension in primary hyperparathyroidism\u2014pre- and postoperative blood pressure in 75 cases. Klin Wochenschr 62:465\u2013469","journal-title":"Klin Wochenschr"},{"key":"26_CR78","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1210\/jc.2009-1588","volume":"94","author":"D Rizzoni","year":"2009","unstructured":"Rizzoni D, Porteri E, De Ciuceis C, Rodella LF, Paiardi S, Rizzardi N et al (2009) Hypertrophic ulticentre of subcutaneous small resistance arteries in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 94:5010\u20135018","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF et al (2014) An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 63:151\u2013160","journal-title":"Hypertension"},{"key":"26_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6065\/apem.2015.20.1.1","volume":"20","author":"T Sahakitrungruang","year":"2015","unstructured":"Sahakitrungruang T (2015) Clinical and molecular review of atypical congenital adrenal hyperplasia. Ann Pediatr Endocrinol Metab 20:1\u20137","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"26_CR81","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR et al (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:351\u2013365","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR82","doi-asserted-by":"publisher","unstructured":"Speiser PW (2015) Congenital adrenal hyperplasia. F1000Res; 4(F1000 Faculty Rev): 601.","DOI":"10.12688\/f1000research.6543.1"},{"key":"26_CR83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5494\/wjh.v5.i2.14","volume":"5","author":"RM Thomas","year":"2015","unstructured":"Thomas RM, Ruel E, Shantavasinkul PC, Corsino L (2015) Endocrine hypertension: an overview on the current etiopathogenesis and management options. World J Hypertens 5:14\u201327","journal-title":"World J Hypertens"},{"key":"26_CR84","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.maturitas.2013.12.009","volume":"77","author":"A Tsirlin","year":"2014","unstructured":"Tsirlin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA (2014) Pheochromocytoma: a review. Maturitas 77:229\u2013238","journal-title":"Maturitas"},{"key":"26_CR85","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1210\/jc.2011-2508","volume":"97","author":"AJ Lely van der","year":"2012","unstructured":"van der Lely AJ, Biller BM, Brue T et al (2012) Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J Clin Endocrinol Metab 97:1589\u20131597","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR86","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s11886-014-0528-x","volume":"16","author":"A Velasco","year":"2014","unstructured":"Velasco A, Vongpatanasin W (2014) The evaluation and treatment of endocrine forms of hypertension. Curr Cardiol Rep 16:528","journal-title":"Curr Cardiol Rep"},{"key":"26_CR87","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/jch.12598","volume":"17","author":"LP Wang","year":"2015","unstructured":"Wang LP, Yang KQ, Jiang XJ, Wu HY, Zhang HM, Zou YB et al (2015) Prevalence of Liddle syndrome among young hypertension patients of undetermined cause in a Chinese population. J Clin Hypertens (Greenwich) 17:902\u2013907","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"26_CR88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/jch.12237","volume":"16","author":"MA Weber","year":"2014","unstructured":"Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG et al (2014) Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) 16:14\u201326","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"26_CR89","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Wermers","year":"2006","unstructured":"Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS et al (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease. J Bone Miner Res 21:171\u2013177","journal-title":"J Bone Miner Res"},{"key":"26_CR90","unstructured":"World Health Organization. Obesity and overweight. 2015. [assessed 30 November 2015]. Available from URL: http:\/\/apps.who.int\/iris\/bitstream\/10665\/79059\/1\/WHO_DCO_WHD_2013.2_eng.pdf?ua=1"},{"key":"26_CR91","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young WF (2007) Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607\u2013618","journal-title":"Clin Endocrinol (Oxf)"},{"key":"26_CR92","first-page":"556","volume-title":"Williams textbook of endocrinology","author":"WF Young Jr","year":"2015","unstructured":"Young WF Jr (2015) Endocrine hypertension. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams textbook of endocrinology, 13th edn. Elsevier, New York, pp 556\u2013588","edition":"13"},{"key":"26_CR93","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/EJE-12-0813","volume":"169","author":"MC Zennaro","year":"2013","unstructured":"Zennaro MC, Rickard AJ, Boulkroun S (2013) Genetics of mineralocorticoid excess: an update for clinicians. Eur J Endocrinol 169:R15\u2013R25","journal-title":"Eur J Endocrinol"},{"key":"26_CR94","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1530\/JOE-14-0597","volume":"224","author":"MC Zennaro","year":"2015","unstructured":"Zennaro MC, Boulkroun S, Fernandes-Rosa F (2015a) An update on novel mechanisms of primary aldosteronism. J Endocrinol 224:R63\u2013R77","journal-title":"J Endocrinol"},{"key":"26_CR95","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.beem.2015.04.010","volume":"29","author":"MC Zennaro","year":"2015","unstructured":"Zennaro MC, Boulkroun S, Fernandes-Rosa F (2015b) Inherited forms of mineralocorticoid hypertension. Best Pract Res Clin Endocrinol Metab 29:633\u2013645","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Advances in Experimental Medicine and Biology","Hypertension: from basic research to clinical practice"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2016_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T14:57:27Z","timestamp":1568559447000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2016_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319442501","9783319442518"],"references-count":95,"URL":"https:\/\/doi.org\/10.1007\/5584_2016_26","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}